[Capreomycin therapy of vesicorenal tuberculosis].
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003558:Cystoscopy; D004977:Ethambutol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D011859:Radiography; D014398:Tuberculosis, Renal / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014401:Tuberculosis, Urogenital / Q000188:drug therapy*; D001745:Urinary Bladder Diseases / Q000188:drug therapy*; D014556:Urine / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D004977:Ethambutol